Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in JapanSatoshi Watanabe, Tomohide Tamura, Mitsuhiro Takenoyama et al.|Lung Cancer|2019Cited by 38
Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCMSatoshi Watanabe, Kazuhiko Nakagawa, Hiroshige Yoshioka et al.|ESMO Open|2024Cited by 4